Suxiao Jiuxin Pill alleviates myocardial ischemia–reperfusion injury through the ALKBH5/GSK3β/mTOR pathway

BACKGROUND: Many studies have shown effective protection from myocardial ischemia–reperfusion injury (MIRI) in animal models, but few, if any, treatments have yielded a substantial reduction in clinical. Several studies showed significant therapeutic effects for the Chinese patent medicine Suxiao Ji...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yiping, Lu, Ruixia, Niu, Zhenchao, Wang, Dan, Wang, Xiaolong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037824/
https://www.ncbi.nlm.nih.gov/pubmed/36959603
http://dx.doi.org/10.1186/s13020-023-00736-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037824/
https://www.ncbi.nlm.nih.gov/pubmed/36959603
http://dx.doi.org/10.1186/s13020-023-00736-6

Ejemplares similares